ClinicalTrials.govpublic full text
Low-dose IL-2 Treatment on Behcet's Disease
behcet's disease, behçet's syndrome, ld-il-2 therapy, treg cells, t follicular cells, th17 cells, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 812544
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.